The Changing Environment Around Accelerated Approvals and Regulatory Pathways - a podcast by Pharma Talk Radio

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss:
How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway
Speakers:
Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Further episodes of PharmaTalkRadio

Further podcasts by Pharma Talk Radio

Website of Pharma Talk Radio